Immunohistochemical examination of Aκ amyloidosis with antibody against adjacent portion of the carboxy terminus of immunoglobulin kappa light chain

Medical Molecular Morphology

Volumn 45, Issue 3, 2012, Pages 124-128

  Hoshii, Yoshinobu ^a   Nanbara, Hidemi ^a   Cui, Dan ^a   Takahashi, Mutsuo ^a   Ikeda, Eiji ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Amyloidosis; Carboxy terminus; Constant region; Immunoglobulin kappa light chain; Immunohistochemistry

Indexed keywords

AMYLOID; EPITOPE; IMMUNOGLOBULIN KAPPA CHAIN; MONOCLONAL ANTIBODY;

AMINO ACID SEQUENCE; AMYLOIDOSIS; ANTIGEN ANTIBODY REACTION; ARTICLE; CARBOXY TERMINAL SEQUENCE; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN CONSTANT REGION; IMMUNOHISTOCHEMISTRY; MOLECULAR CLONING; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; AMYLOID; AMYLOIDOSIS; ANIMALS; ANTIBODIES; HUMANS; IMMUNOGLOBULIN KAPPA-CHAINS; IMMUNOHISTOCHEMISTRY; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; RABBITS;

EID: 84871438463     PISSN: 18601480     EISSN: 18601499     Source Type: Journal    
DOI: 10.1007/s00795-011-0548-1     Document Type: Article

References (17)

1. Sipe JD, Benson MD, Buxbaum JN, Ikeda S, Merlini G, Saraiva MJ, Westermark P (2010) Amyloid fi bril protein nomenclature: 2010 recommendations from the nomenclature committee of the International Society of Amyloidosis. Amyloid 17:101-104
2. Buxbaum J (1992) Mechanisms of disease: monoclonal immunoglobulin deposition. Amyloidosis, light chain deposition disease, and light and heavy chain deposition disease. Hematol Oncol Clin N Am 6:323-346
3. Olsen KE, Sletten K, Westermark P (1998) Fragments of the constant region of immunoglobulin light chains are constituents of AL-amyloid proteins. Biochem Biophys Res Commun 251:642-647 (Pubitemid 28505076)
4. Engvig JP, Olsen KE, Gislefoss RE, Sletten K, Wahlström O, Westermark P (1998) Constant region of a kappa III immunoglobulin light chain as a major AL-amyloid protein. Scand J Immunol 48:92-98 (Pubitemid 28329158)
5. Solomon A, Weiss DT, Murphy CL, Hrncic R, Wall JS, Schell M (1998) Light chain-associated amyloid deposits comprised of a novel kappa constant domain. Proc Natl Acad Sci U S A 95:9547-9551 (Pubitemid 28506268)
6. Wally J, Kica G, Zhang Y, Ericsson T, Connors LH, Benson MD, Liepnieks JJ, Murray J, Skinner M, Comenzo RL (1999) Identifi cation of a novel substitution in the constant region of a gene coding for an amyloidogenic kappa1 light chain. Biochim Biophys Acta 31:49-56 (Pubitemid 29238097)
7. Yamamoto K, Yagi H, Lee YH, Kardos J, Hagihara Y, Naiki H, Goto Y (2010) The amyloid fi brils of the constant domain of immunoglobulin light chain. FEBS Lett 584:3348-3353
8. Hoshii Y, Setoguchi M, Iwata T, Ueda J, Cui D, Kawano H, Gondo T, Takahashi M, Ishihara T (2001) Useful polyclonal antibodies against synthetic peptides corresponding to immunoglobulin light chain constant region for immunohistochemical detection of immunoglobulin light chain amyloidosis. Pathol Int 51:264-270 (Pubitemid 32472697)
9. Hoshii Y, Kiyama M, Cui D, Kawano H, Ishihara T (2006) Immunohistochemical study of immunoglobulin light chain amyloidosis with antibodies to the immunoglobulin light chain variable region. Pathol Int 56:324-330 (Pubitemid 43725401)
10. Imada N (1981) Pathological study on amyloidosis. Isolation and purifi cation of amyloid fi bril protein and biochemical and immunological analysis (in Japanese). Yamaguchi Med J 30:149-162
11. Gustavsson A, Engström U, Westermark P (1994) Mechanisms of transthyretin amyloidogenesis. Antigenic mapping of transthyretin purifi ed from plasma and amyloid fi brils and within in situ tissue localizations. Am J Pathol 144:1301-1311 (Pubitemid 24172092)
12. Kitamoto T, Ogomori K, Tateishi J, Prusiner SB (1987) Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids. Lab Invest 57:230-236 (Pubitemid 17138778)
13. Ozaki S, Abe M, Wolfenbarger D, Weiss DT, Solomon A (1994) Preferential expression of human lambda-light-chain variableregion subgroups in multiple myeloma, AL amyloidosis, and Waldenström's macroglobulinemia. Clin Immunol Immunopathol 71:183-189 (Pubitemid 24147235)
14. Enqvist S, Sletten K, Westermark P (2009) Fibril protein fragmentation pattern in systemic AL-amyloidosis. J Pathol 219:473-480
15. Glenner GG, Ein D, Eanes ED, Bladen HA, Terry W, Page DL (1971) Creation of "amyloid" fi brils from Bence Jones proteins in vitro. Science 174:712-714
16. Linke RP, Zucker-Franklin D, Franklin ED (1973) Morphologic, chemical, and immunologic studies of amyloid-like fi brils formed from Bence Jones proteins by proteolysis. J Immunol 111:10-23
17. Röcken C, Hegenbarth V, Schmitz M, Stix B, Schade G, Mohnert A, Roessner A (2000) Plasmacytoma of the tonsil with AL amyloidosis: evidence of post-fi brillogenic proteolysis of the fi bril protein. Virchows Arch 436:336-344 (Pubitemid 30219231)